CollPlant Biotechnologies Ltd (CLGN) Unusual Options Activity Today

Checking CLGN unusual options activity helps you spot when traders are making outsized bets on CollPlant Biotechnologies Ltd before the broader market catches on. CollPlant Biotechnologies Ltd's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor CLGN unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching CLGN unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking CLGN unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and CLGN unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds.

It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.

Catalysts rarely arrive without a footprint, and CLGN unusual options activity is often where that footprint shows up first. Our scanner tracks CollPlant Biotechnologies Ltd's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at CLGN unusual options volume on the call side or chasing put sweeps, CollPlant Biotechnologies Ltd's unusual options flow today is one click away, so put it on your radar before the headlines hit.